Nome |
# |
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management, file e309ade3-e7e4-3969-e053-3a05fe0a2c94
|
334
|
Uric acid and coronary artery disease: An elusive link deserving further attention, file e309ade0-ce37-3969-e053-3a05fe0a2c94
|
263
|
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study, file e309ade3-424d-3969-e053-3a05fe0a2c94
|
184
|
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome, file e309ade3-47f9-3969-e053-3a05fe0a2c94
|
127
|
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial, file e309ade2-4928-3969-e053-3a05fe0a2c94
|
120
|
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials, file e309ade4-c766-3969-e053-3a05fe0a2c94
|
120
|
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial, file e309ade4-96df-3969-e053-3a05fe0a2c94
|
97
|
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study, file e309ade2-da97-3969-e053-3a05fe0a2c94
|
90
|
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial, file e309ade4-9873-3969-e053-3a05fe0a2c94
|
89
|
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study, file e309ade4-7810-3969-e053-3a05fe0a2c94
|
88
|
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease, file e309ade3-9a5e-3969-e053-3a05fe0a2c94
|
64
|
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis, file e309ade2-e11d-3969-e053-3a05fe0a2c94
|
63
|
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF), file e309ade4-9725-3969-e053-3a05fe0a2c94
|
60
|
Fractional flow reserve: Current applications and overview of the available data, file e309ade4-b3a4-3969-e053-3a05fe0a2c94
|
49
|
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis, file 84320e54-d0dd-4115-8988-803f6494a251
|
47
|
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome, file e7391ba1-d6ee-4c32-ae1a-aab605199013
|
47
|
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial, file e309ade4-9506-3969-e053-3a05fe0a2c94
|
46
|
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure, file e309ade4-d385-3969-e053-3a05fe0a2c94
|
46
|
Functional Assessment and Acute Coronary Syndrome, file e309ade5-2a48-3969-e053-3a05fe0a2c94
|
46
|
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study, file e309ade4-7774-3969-e053-3a05fe0a2c94
|
43
|
Angina and chronic obstructive pulmonary disease: facing the perfect storm, file e309ade4-933a-3969-e053-3a05fe0a2c94
|
43
|
Angina and left ventricular dysfunction: can we "reduce' it?, file e309ade4-b9bc-3969-e053-3a05fe0a2c94
|
37
|
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies, file e309ade4-a7be-3969-e053-3a05fe0a2c94
|
36
|
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings, file e309ade4-2fdf-3969-e053-3a05fe0a2c94
|
34
|
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management, file e309ade3-e7e5-3969-e053-3a05fe0a2c94
|
21
|
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology, file 9c796f8b-c908-4c96-ab0a-2fbf8f96a0a9
|
16
|
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease, file e309ade3-cfc2-3969-e053-3a05fe0a2c94
|
16
|
Can we improve myocardial protection during ischaemic injury?, file e309ade0-cf79-3969-e053-3a05fe0a2c94
|
15
|
Frailty in patients admitted to hospital for acute coronary syndrome: when, how and why?, file e309ade4-b89a-3969-e053-3a05fe0a2c94
|
12
|
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine, file 01eb4979-81ac-47e2-88dc-6d93e6410fff
|
11
|
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction, file cd166daa-4201-454f-8cba-8f12a6c2eb08
|
9
|
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies, file cfb144be-c6a1-4696-bed6-a7327f18f6d3
|
9
|
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease, file e309ade4-9336-3969-e053-3a05fe0a2c94
|
8
|
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review, file 21d76940-1ab2-4a6e-a3f0-ef96ca420fc8
|
6
|
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study, file bad26bc5-1579-47ba-bb17-f8d7938af28b
|
5
|
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network, file e309ade1-2ed5-3969-e053-3a05fe0a2c94
|
5
|
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree?, file ff9a4340-7f73-40e5-af9a-135515a94eda
|
5
|
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy, file b0d817f6-2598-4f52-92e0-17752a64fee3
|
4
|
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19, file d630ada3-5f10-415c-ac6f-7069db6a4106
|
4
|
Nutritional status and all-cause mortality in older adults with acute coronary syndrome, file e309ade3-b137-3969-e053-3a05fe0a2c94
|
4
|
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial, file e309ade4-8f44-3969-e053-3a05fe0a2c94
|
4
|
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold, file a2fa1f4e-cbe4-438a-b474-7c931ef39dfa
|
3
|
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial, file cf23c6fb-b63a-4266-aa14-a91306f5aa24
|
3
|
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study, file e309ade1-2c2a-3969-e053-3a05fe0a2c94
|
2
|
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study), file e309ade1-3158-3969-e053-3a05fe0a2c94
|
2
|
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction, file e309ade4-b8ac-3969-e053-3a05fe0a2c94
|
2
|
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention, file d62ab04e-aa2f-404e-bd65-7d55a5872de1
|
1
|
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study, file e309ade0-9dba-3969-e053-3a05fe0a2c94
|
1
|
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings, file e309ade0-d00b-3969-e053-3a05fe0a2c94
|
1
|
null, file e309ade0-d753-3969-e053-3a05fe0a2c94
|
1
|
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study), file e309ade0-d961-3969-e053-3a05fe0a2c94
|
1
|
Reperfusion Damage - A Story of Success, Failure, and Hope, file e309ade1-2d78-3969-e053-3a05fe0a2c94
|
1
|
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial, file e309ade1-3790-3969-e053-3a05fe0a2c94
|
1
|
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials, file e309ade1-a3d1-3969-e053-3a05fe0a2c94
|
1
|
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention, file e309ade1-aa62-3969-e053-3a05fe0a2c94
|
1
|
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease, file e309ade3-4066-3969-e053-3a05fe0a2c94
|
1
|
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management, file e309ade3-4586-3969-e053-3a05fe0a2c94
|
1
|
Uric acid and coronary artery disease: An elusive link deserving further attention, file e309ade3-a31c-3969-e053-3a05fe0a2c94
|
1
|
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial, file e309ade3-b510-3969-e053-3a05fe0a2c94
|
1
|
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis, file e309ade3-e0e6-3969-e053-3a05fe0a2c94
|
1
|
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome, file e309ade4-6ce2-3969-e053-3a05fe0a2c94
|
1
|
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis, file e309ade4-81b2-3969-e053-3a05fe0a2c94
|
1
|
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study, file e309ade4-de7d-3969-e053-3a05fe0a2c94
|
1
|
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review, file e7a09c8f-5fed-41e2-9d1c-6ab4a41ff733
|
1
|
Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study, file ed640e48-6112-4cf8-8a4f-9183e36ab20d
|
1
|
Impact of Diabetes on 10-Year Outcomes Following ST-Segment-Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial, file ff7468d5-0d6e-46b9-8472-a3bf37785887
|
1
|
Totale |
2.359 |